索宝蛋白
(603231)
| 流通市值：8.29亿 | | | 总市值：33.14亿 |
| 流通股本：4786.48万 | | | 总股本：1.91亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,155,092,649.3 | 772,006,015.52 | 392,657,748.16 | 1,747,597,943.27 |
| 营业收入 | 1,155,092,649.3 | 772,006,015.52 | 392,657,748.16 | 1,747,597,943.27 |
| 二、营业总成本 | 1,073,407,161.58 | 709,903,475.59 | 353,409,968.35 | 1,579,155,666.03 |
| 营业成本 | 1,026,920,691.28 | 681,399,841.39 | 345,055,718.85 | 1,509,084,082.18 |
| 税金及附加 | 5,314,028.72 | 3,825,849.49 | 1,163,976.63 | 7,015,162.36 |
| 销售费用 | 14,291,897.46 | 9,539,464.86 | 3,957,105.33 | 19,925,933.62 |
| 管理费用 | 26,420,500.42 | 18,162,733.64 | 6,944,737.5 | 32,503,805.06 |
| 研发费用 | 8,089,606.75 | 6,400,049.57 | 1,329,836.11 | 10,445,666.82 |
| 财务费用 | -7,629,563.05 | -9,424,463.36 | -5,041,406.07 | 181,015.99 |
| 其中:利息费用 | 132,091.56 | 127,598.37 | 115,782.94 | 2,557,883.83 |
| 其中:利息收入 | 5,813,425.7 | 5,020,348.43 | 3,186,400.26 | 642,482.92 |
| 加:公允价值变动收益 | 2,069,361.07 | 4,302,516.27 | - | - |
| 加:投资收益 | 7,085,298.38 | 1,728,241.94 | 62,638.57 | 21,539.95 |
| 资产处置收益 | 91,590.42 | 91,568.26 | 53,691.73 | 378,510.39 |
| 资产减值损失(新) | - | - | - | -734,602.11 |
| 信用减值损失(新) | 4,858,715.28 | 4,286,367.94 | 4,938,455.8 | -1,201,574.02 |
| 其他收益 | 14,966,791.57 | 13,551,100.19 | 2,752,239.21 | 17,042,364.09 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 110,757,244.44 | 86,062,334.53 | 47,054,805.12 | 183,948,515.54 |
| 加:营业外收入 | 273,986.21 | 161,369.12 | 124,315.89 | 214,465.54 |
| 减:营业外支出 | 1,939,049.51 | 1,778,125.17 | 1,834,664.4 | 7,555,991.59 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 109,092,181.14 | 84,445,578.48 | 45,344,456.61 | 176,606,989.49 |
| 减:所得税费用 | 17,411,650.06 | 13,647,571.02 | 8,078,986.86 | 26,263,081.13 |
| 六、净利润 | 91,680,531.08 | 70,798,007.46 | 37,265,469.75 | 150,343,908.36 |
| 其中:被合并方在合并前实现利润 | - | -1,906,750.73 | - | - |
| 持续经营净利润 | 91,680,531.08 | 70,798,007.46 | 37,265,469.75 | 150,343,908.36 |
| 归属于母公司股东的净利润 | 91,680,531.08 | 70,798,007.46 | 37,265,469.75 | 150,343,908.36 |
| (一)基本每股收益 | 0.48 | 0.37 | 0.19 | 1.05 |
| (二)稀释每股收益 | 0.48 | 0.37 | 0.19 | 1.05 |
| 九、综合收益总额 | 91,680,531.08 | 70,798,007.46 | 37,265,469.75 | 150,343,908.36 |
| 归属于母公司股东的综合收益总额 | 91,680,531.08 | 70,798,007.46 | 37,265,469.75 | 150,343,908.36 |
| 公告日期 | 2024-10-26 | 2024-08-30 | 2024-04-30 | 2024-04-20 |
| 审计意见(境内) | | | | 标准无保留意见 |